Jupiter Life Line Hospital
add_icon

Jupiter Life Line Hospital

1,258.20
-10.70
(-0.84%)
Market Cap
8,249.52 Cr
PE Ratio
43.95
Volume
13,036.00
Day High - Low
1,272.90 - 1,235.40
52W High-Low
1,770.00 - 1,198.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
8,249.52 Cr
EPS
29.47
PE Ratio
43.95
PB Ratio
5.72
Book Value
221.29
EBITDA
325.20
Dividend Yield
0.08 %
Sector
Hospitals
Return on Equity
14.27
Debt to Equity
0.16
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
ICRA assigns [ICRA]AA- (Stable) rating to Jupiter Hospital Projects' Rs. 250 crore term loan and [ICRA]A1+ rating to short-term facilities totaling Rs. 255 crore bank facilities.
neutral
Jupiter Life Line Hospitals Limited announces investor conference on February 25, 2026, organized by Kotak Institutional Equities in Mumbai from 11:00 am to 05:00 pm.
neutral
Jupiter Life Line Hospitals Limited has scheduled an analyst and institutional investor meeting for February 10, 2026, at the Nuvama Conference in Mumbai from 2:00 pm to 5:00 pm.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,145.00
#1 1,02,734.14
56.74
#1 21,994.30
14.76
#1 1,505
36.08
33.69
956.90
93,084.30
66.17
7,184.10
#1 28.65
1,076
26.01
31.20
799.20
60,336.26
63.24
7,849.70
13.25
809
-22.38
33.26
1,624.60
33,200.46
43.35
5,575.00
12.29
790
-34.33
32.92
621.30
32,190.86
90.51
4,286.70
15.12
337
-8.85
43.82
969.60
26,061.92
52.56
3,771.40
12.59
481
-33.52
23.74
630.50
25,228.76
82.22
3,067.00
21.98
415
-43.89
38.88
420.20
13,298.07
83.68
1,757.00
27.65
110
#1 54.61
35.32
5,155.50
11,533.32
#1 24.44
599.90
11.69
58
12.46
43.87
1,106.00
11,232.44
43.65
1,566.90
17.46
244
7.26
34.09

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
17.77 %
Net Income Growth
9.57 %
Cash Flow Change
121.18 %
ROE
-5.56 %
ROCE
-18.82 %
EBITDA Margin (Avg.)
4.56 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
203
224
231
246
248
267
281
302
296
343
340
334
366
405
375
Expenses
151
166
183
193
192
203
211
228
223
257
257
249
275
301
288
EBITDA
51
58
48
53
57
64
70
74
72
86
84
85
91
104
86
Operating Profit %
25 %
25 %
20 %
20 %
21 %
23 %
23 %
22 %
23 %
23 %
23 %
24 %
22 %
23 %
21 %
Depreciation
9
10
10
10
11
11
11
10
11
14
14
18
21
22
22
Interest
10
10
11
11
12
12
1
1
1
1
3
6
8
8
8
Profit Before Tax
32
38
27
32
34
41
58
62
60
70
67
62
62
74
57
Tax
2
11
27
16
-20
8
14
17
16
18
15
17
18
17
14
Net Profit
31
27
-0
16
54
34
44
45
45
52
52
45
44
58
43
EPS in ₹
5.99
5.32
-0.12
3.04
9.93
5.67
6.56
6.49
6.80
7.88
7.95
6.84
6.69
8.75
6.49

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
603
789
909
986
1,281
1,905
Fixed Assets
435
630
684
720
718
977
Current Assets
134
113
180
209
410
687
Capital Work in Progress
11
26
27
29
74
185
Investments
2
7
3
2
17
114
Other Assets
156
126
195
235
473
628
Total Equity & Liabilities
603
789
909
986
1,281
1,905
Current Liabilities
103
96
123
132
106
152
Non Current Liabilities
263
447
497
490
7
396
Total Equity
237
246
288
364
1,169
1,356
Reserve & Surplus
186
188
241
309
1,104
1,291
Share Capital
51
51
51
57
66
66

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
13
85
31
-4
345
Investing Activities
-43
-295
-84
-104
-246
-209
Operating Activities
74
123
137
117
115
253
Financing Activities
-32
184
32
18
128
301

Share Holding

% Holding
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
40.91 %
FIIs
0.00 %
0.00 %
4.17 %
6.06 %
8.84 %
10.04 %
10.03 %
9.77 %
9.06 %
8.48 %
DIIs
12.33 %
13.59 %
17.58 %
17.27 %
16.87 %
15.74 %
15.63 %
15.82 %
16.95 %
17.43 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
29.91 %
28.01 %
27.78 %
26.31 %
24.39 %
24.45 %
24.54 %
24.64 %
24.37 %
24.36 %
Others
16.85 %
17.49 %
9.56 %
9.45 %
8.98 %
8.85 %
8.88 %
8.86 %
8.70 %
8.82 %
No of Share Holders
2,13,467
39,348
35,107
35,797
34,081
33,914
33,956
34,192
34,361
33,620

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.08 0.00

Announcements

Announcement under Regulation 30 (LODR)-Credit RatingMar 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Commencement Of Operations At Jupiter Hospital Dombivli Mumbai Metropolitan Region.Jan 30, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 30, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated January 30 2026Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 23, 2026
Board Meeting Intimation for Prior Intimation Of The Board Meeting To Be Held On Friday January 30 2026Jan 23, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Closure of Trading WindowDec 24, 2025
Announcement under Regulation 30 (LODR)-RestructuringNov 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated November 07 2025Nov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Board Meeting Intimation for Prior Intimation Of The Board Meeting To Be Held On Friday November 07 2025Nov 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 01, 2025
Clarification Regarding The News ArticleOct 13, 2025
Clarification sought from Jupiter Life Line Hospitals LtdOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-RestructuringSep 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 09, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2025
Intimation Under Regulation 30(5) Of The Listing RegulationAug 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Outcome Of Board Meeting Dated August 01 2025Aug 01, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated August 01 2025Aug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 25, 2025
Board Meeting Intimation for Notice Of The Board Meeting To Be Held On Friday August 01 2025Jul 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 11, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 20, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 18, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Quality Fund Direct-Growth
0.00%
-65378
-0.38%
-0.72%
Bandhan Innovation Fund Direct-Growth
0.46%
0
0.00%
-0.36%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Axis Retirement Fund - Aggressive Plan Direct-Growth
0.00%
0
0.00%
0.00%
Axis Retirement Fund - Dynamic Plan Direct-Growth
0.00%
0
0.00%
0.00%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
-0.21%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.35%
0
0.00%
-0.04%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
0.74%
0
0.00%
-0.13%
PGIM India Healthcare Fund Direct-Growth
2.12%
0
0.00%
-0.25%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.01%
0
-0.11%
-0.06%
Baroda BNP Paribas Large & Mid Cap Fund Direct - Growth
0.94%
0
0.00%
-0.07%
DSP Healthcare Fund Direct - Growth
0.39%
0
0.00%
-0.04%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Consumption Fund Direct-Growth
1.37%
0
0.00%
-0.08%
ICICI Prudential Balanced Advantage Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Exports and Services Fund Direct-Growth
0.58%
0
0.00%
-0.04%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.94%
0
0.00%
-0.25%
Axis Multicap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Small Cap Fund Direct-Growth
0.17%
0
0.00%
-0.02%
Baroda BNP Paribas Balanced Advantage Fund Direct - Growth
0.70%
0
0.00%
-0.06%
Samco Active Momentum Fund Direct - Growth
0.00%
0
0.00%
0.00%
SBI Healthcare Opportunities Fund Direct Plan-Growth
2.79%
0
0.00%
-0.39%
SBI Mid Cap Direct Plan-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
49.41
ATR(14)
Volatile
42.68
STOCH(9,6)
Neutral
48.98
STOCH RSI(14)
Neutral
61.30
MACD(12,26)
Bullish
3.29
ADX(14)
Weak Trend
8.80
UO(9)
Bearish
55.12
ROC(12)
Downtrend And Accelerating
-1.73
WillR(14)
Neutral
-49.70